These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39071579)

  • 1. Ginsenoside Rg1 inhibits multiple myeloma and overcomes bortezomib resistance through AMPK-mTOR pathway.
    Lin L; Chen D; Li S; Wang T
    Heliyon; 2024 Jul; 10(13):e33935. PubMed ID: 39071579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages.
    Yang P; Ling L; Sun W; Yang J; Zhang L; Chang G; Guo J; Sun J; Sun L; Lu D
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):144-155. PubMed ID: 29324976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cdc37 Contributes to bortezomib resistance in multiple myeloma via autophagy].
    Liu LT; Deng SH; Zang MR; Zhang JQ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):583-588. PubMed ID: 32810966
    [No Abstract]   [Full Text] [Related]  

  • 4. Ginsenoside Rg1 Induces Autophagy in Colorectal Cancer through Inhibition of the Akt/mTOR/p70S6K Pathway.
    Liu R; Zhang B; Zou S; Cui L; Lin L; Li L
    J Microbiol Biotechnol; 2024 Apr; 34(4):774-782. PubMed ID: 38668684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
    Li W; Li G; She W; Hu X; Wu X
    J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro.
    Chen J; Zhu G; Xiao W; Huang X; Wang K; Zong Y
    Diabetes Metab Syndr Obes; 2023; 16():779-794. PubMed ID: 36945297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.
    Mao N; Tan RZ; Wang SQ; Wei C; Shi XL; Fan JM; Wang L
    Cell Biol Int; 2016 Aug; 40(8):917-25. PubMed ID: 27296076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IL-6 Regulates the Chemosensitivity of Drug-Resistant Multiple Myeloma Cell Lines to Bortezomib through STAT3/Notch Signaling Pathway].
    Liu Y; Sui JZ; Zhu LH; Dai Y; Dong HQ; Cheng P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1474-1481. PubMed ID: 36208252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma.
    Yao Y; Zhang Y; Shi M; Sun Y; Chen C; Niu M; Zhang Q; Zeng L; Yao R; Li H; Yang J; Li Z; Xu K
    J Leukoc Biol; 2018 Dec; 104(6):1105-1115. PubMed ID: 30024656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway.
    Wu H; Qu L; Bai X; Zhu C; Liu Y; Duan Z; Liu H; Fu R; Fan D
    Food Chem Toxicol; 2024 Apr; 186():114587. PubMed ID: 38461953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.
    Zhang M; He J; Liu Z; Lu Y; Zheng Y; Li H; Xu J; Liu H; Qian J; Orlowski RZ; Kwak LW; Yi Q; Yang J
    Oncotarget; 2015 Apr; 6(11):8567-78. PubMed ID: 25895124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms].
    Mo HM; Wu QY; Han DY; Liu R; Ma X; Zhou P; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1053-1057. PubMed ID: 29365400
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Bushen Yanggu Decoction on Multidrug Resistance of Multiple Myeloma Cell Line KM3/BTZ].
    Li YP; Zhang JG; Fang ZQ; Huang XR; Chen X; Li ZJ; Fang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):482-488. PubMed ID: 30998158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rg1 protects starving H9c2 cells by dissociation of Bcl-2-Beclin1 complex.
    Li D; Wang J; Hou J; Fu J; Chang D; Bensoussan A; Liu J
    BMC Complement Altern Med; 2016 May; 16():146. PubMed ID: 27228978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis.
    Tian FQ; Chen ZR; Zhu W; Tang MQ; Li JH; Zhang XC; Jiang J; Cheng XH
    J Gene Med; 2021 Sep; 23(9):e3329. PubMed ID: 33625798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg1 regulates autophagy and endoplasmic reticulum stress via the AMPK/mTOR and PERK/ATF4/CHOP pathways to alleviate alcohol‑induced myocardial injury.
    Tian G; Li J; Zhou L
    Int J Mol Med; 2023 Jul; 52(1):. PubMed ID: 37232350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K/AKT/mTOR pathway.
    Qin L; Fan S; Jia R; Liu Y
    Pharmazie; 2018 Jun; 73(6):349-355. PubMed ID: 29880088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.
    Xing JJ; Hou JG; Ma ZN; Wang Z; Ren S; Wang YP; Liu WC; Chen C; Li W
    Cell Prolif; 2019 Jul; 52(4):e12627. PubMed ID: 31094028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma.
    Li Z; Wang H; Wang Y; Ma Z; Hu L; Luo S; Gong Y; Zhu L; Gong H; Xiang R; Zhu Y; Xie Y; Yang C; Peng H; Liu J; Xiao X
    Cancer Lett; 2023 Feb; 554():216019. PubMed ID: 36442773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.